Extend Biosciences

Extend Biosciences is a clinical-stage biopharmaceutical company that utilizes its platform technology to develop next-generation therapeutic peptides with superior pharmacokinetic properties. Its proprietary technology, D-VITylation®, leverages the biological properties of vitamin D and the reversible binding characteristics of serum circulating vitamin D binding protein. By utilizing this natural pathway, D-VITylation® prevents renal clearance of vitamin D-bound therapeutics, thereby significantly extending their half-life without compromising bioactivity.